Abstract For many years, research on bovine papillomavirus (BPV) has contributed to the understanding of papillomavirus-induced pathology in humans and animals. The present review shows how recent studies on BPV keep providing evidence concerning key points in viral infection, such as the expression of viral proteins in lymphocytes and the occurrence of productive infections of the placenta. Studies on BPV-induced tumours also provide important information concerning the mechanisms of oncogenesis and immune evasion, as in the cases of connexin 43 down-regulation with loss of intercellular gap junctions and Toll-like receptor 4 (TLR4) down-regulation in equine sarcoids. The biological functions of viral proteins are also being further clarified, as in the case of E2, which was recently shown to load BPV genomes into host chromosomes during the S phase, a process mediated by the ChlR1 protein. In the near future, the ongoing efforts to characterize and classify additional emerging BPV types are likely to broaden even further the possibilities for research.
Introduction
Animal papillomavirus such as bovine papillomavirus (BPV), cottontail rabbit papillomavirus, and canine oral papillomavirus have long been known to induce tumours in their host species. In fact, these viruses first provided evidence for virus-induced carcinogenesis and have since been used as models to study the biology and pathology of human papillomavirus (HPV), as reviewed by Campo [1] . Papillomavirus are highly species-specific, making animal models for HPV difficult to obtain, except by using animal papillomavirus. Even though these difficulties in finding experimental models of HPV infection and carcinogenesis have been largely overcome during the first years of the new century, with the development of HPV-transfected organotypic cell cultures [2] , research on animal papillomavirus, and particularly on BPV, does not seem to have diminished since then.
This review will deal with selected recent literature on animal papillomavirus, especially with those papers published over the last two years. Emphasis will be placed on BPV, since it causes several important syndromes and great losses among infected animals. Urinary bladder tumours associated with BPV infection caused losses worth over 4 million euros in state compensation and insurance paid to affected milk producers in the Azores between 2000 and 2006 [3] , but this may be an underestimate. Research on BPV has led to most of the recent breakthroughs on the biology and pathology of animal papillomavirus, with major implications for human health. Using such spontaneous models, researchers have recently made significant discoveries on the interaction of papillomavirus with chemical carcinogens and immunosuppressants [4] , on the role of BPV oncoproteins in cell transformation and immune evasion, on the infection of some unusual cell types and the possibility of haematogenous transplacental BPV transmission [5] , and on new prophylactic and therapeutic vaccines [6] [7] [8] .
In 2008, ten BPV types were recognized [9] , but three new types have recently been proposed [10] [11] [12] . Bovine papillomavirus are grouped into three genera within the family Papillomaviridae: Deltapapillomavirus (BPV-1, BPV-2 and BPV-13), Xipapillomavirus (BPV-3, BPV-4, BPV-6, and BPV-9 to -12) and Epsilonpapillomavirus (BPV-5 and BPV-8), which show important inter-generic differences (e.g. xipapillomaviruses lack the E6 gene) [13] (Fig. 1) . The classification of BPV-7 remains to be determined [14] , and there are at least sixteen other virus strains under study, detected in samples from Brazil, Japan and Sweden, that await classification, as recently reviewed by Zhu and co-workers [11] . In cattle, infection with several different BPV types is associated with the development of cutaneous, udder and teat papillomas and fibropapillomas [15] [16] [17] [18] and cancer of various organ systems. In particular, BPV-4 causes upper digestive tract papillomas, while BPV-2 and, less commonly, BPV-1 are associated with urinary bladder tumours [9] . Papillomavirus are strictly species-specific, with the notable exception of BPV-1 and, to a lesser extent, BPV-2. These two BPV types show a varied tropism for unusual cell types and even for species other than cattle, including equids such as horses, donkeys and zebras, where they cause fibroblast-derived cutaneous sarcoid tumours [19, 20] . The following sections will deal with recent findings regarding BPV-induced tumours and the roles of BPV proteins, the interactions between BPV and chemical carcinogens, viral strategies to develop latency and enhance transmission, and new vaccination strategies. References to HPV and to other animal papillomavirus will be made when appropriate.
BPV-induced cell transformation
Tumours induced by BPV in cattle and horses provide a valuable opportunity for researchers to study the mechanisms through which viral oncoproteins -E5, E6 and E7 -transform infected cells. BPV E5 is a small, hydrophobic protein, mostly located in the in the Golgi apparatus and endoplasmic reticulum, and is considered a major transforming oncoprotein (reviewed by Venutti et al. [21] ). Accordingly, its role in carcinogenesis has long been the focus of intense research. Many of the functions of HPV E5 were first elucidated in BPV models, while some BPV E5 activities are not even shared by HPV E5, such as the activation of PDGFRb and the tyrosine kinase c-src in bovine bladder carcinomas. Bovine papillomavirus type 2 and, less frequently, BPV-1 cause a non-productive infection of the urothelium in cattle, which has been associated with the development of urinary bladder tumours [22, 23] . A similar pathology showing identical features was recently described in Turkish water buffaloes [24] . Several studies on bovine urothelial neoplasms reported the expression of cancer markers (reviewed by Gil da Costa et al. [4] ) such as calpain-3, recently proposed to contribute to carcinogenesis by cleaving pRB [25] . Bovine urinary bladder tumours are often of mesenchymal or mixed mesenchymal/epithelial origin, often involving the endothelium (haemangiomas, haemagiosarcomas). Besides being present in the urothelium, BPV-2 DNA and oncoproteins (E5 and E7) have also been detected in neoplastic endothelial cells, where E5 has also been shown to colocalize with PDGFRb [26] . E5 is believed to be critical in driving cell transformation in vitro and in vivo, through several mechanisms, especially by activating the plateletderived growth factor receptor b (PDGFRb) [21] . As described recently, the binding of BPV-1 E5 to PDGFRb results in activation of the phophatidylinositol-3-kinase (PI3K)-AKT-cyclin D pathway, leading to cell-cycle deregulation [27] . In higher-grade urothelial carcinomas, PDGFRb recruits growth-factor-receptor-bound protein 2 (GRB2) and its constitutively associated protein Sos, Fig. 1 Neighbour-joining phylogenetic tree of bovine papillomaviruses (BPV, blue) and some high-risk human papillomaviruses (HPV, red), based on the L1 nucleotide sequence. Greek letters indicate the genus leading to RAS activation, but not to downstream Erk or Mek phosphorylation [28] . Based on these findings, the PI3K-AKT-cyclin D rather than the RAS-Erk pathway seems to be instrumental in driving papillomavirus-induced urothelial carcinogenesis (Fig. 2) .
The roles of E6 and E7 oncoproteins have also been studied in BPV-induced tumours. Importantly, BPV-1 E6 (together with HPV-1 and -8 E6) has recently been reported to bind the mastermind-like protein 1 (MAML1), repressing the NOTCH pathway and consequent gene transcription [29] . Based on these results, the authors propose that delayed keratinocyte differentiation in papillomavirus-induced papillomas may be a consequence of impaired NOTCH signalling. Despite lacking the canonical pRB-binding motif, BPV E7 plays a significant role in bovine and equine tumours. Infection of the bovine upper gastrointestinal mucosa by BPV-4 leads to papillomatosis of variable extension and severity. Upon prolonged exposure to bracken (Pteridium spp., a carcinogenic fern), papillomas progress to squamous cell carcinomas, providing a useful example of viral and chemical co-carcinogenesis [30] . As recently reviewed by Gil da Costa et al. [4] , malignant transformation seems to depend on the mutagenic and immunosuppressant properties of bracken toxins which, on the one hand, promote genomic instability, resistance to apoptosis, and cell-cycle deregulation by inactivating p53 and activating ras and, on the other hand, prevent the immune system from clearing the viral papillomas (Fig. 3) . The bracken flavonoid quercetin, abundant in fruits and vegetables, also activates transcription from the BPV-4 long control region (LCR), up-regulating E7 expression and contributing to cell transformation in vitro [13] . Bearing in mind that, in human populations, HPV infection has been demonstrated in a significant proportion of oesophageal cancer cases and that bracken exposure is epidemiologically associated with higher oesophageal cancer risk, the hypothesis has been advanced that a similar mechanism may underlie oesophageal carcinogenesis in humans [1] . As with gastrointestinal tumours, bracken toxins are thought to drive the malignant transformation of initial bladder viral lesions. However, the interaction between BPV and bracken is not as clear as in the gastrointestinal tract. In fact, ptaquiloside from bracken is capable of inducing pre-neoplastic and neoplastic bladder lesions in laboratory animals alone, without any viral involvement [4, 31] . Bovine bladder tumours have attracted great interest not only due to their implication for animal health and the dairy industry but also because they constitute a valuable spontaneous model to study the role of viral oncoproteins in cell transformation. BPV E7 is also thought to be important in preventing anoikis, possibly by binding to the retinoblastoma-proteinassociated factor p600 in vitro. Binding of p600 has now also been reported in naturally occurring equine sarcoids, bringing additional support to this hypothesis [32] . Sarcoids are locally aggressive tumoural lesions that develop in equids (horses, donkeys, zebras) from dermal fibroblasts that harbour a latent, most commonly non-productive BPV-1 or BPV-2 infection and maintain the BPV-1/2 genomes in an episomal form [20] . Much interest has been focused on the mechanisms through which BPV-1 and -2 transform equine fibroblasts, causing equine sarcoids. Interestingly, the number of viral DNA copies has been shown to be significantly higher in more-aggressive sarcoids than in their slow-growing counterparts [33] . Over the years, the expression of several cancer markers has been studied in equine sarcoids, such as the tumour suppressor gene fragile histidine triad (FHIT), which was found to be down-regulated [34] as in human cervical cancer [35] , although, curiously, not in BPV-associated bovine urinary tumours [36] . Such differences make spontaneous, BPV-induced, animal cancer models particularly useful to study the influence of a specific host's genes in the carcinogenic process. Overexpression of matrix metalloproteinases (MMP) is an important mechanism involved in tumourigenesis, and this was recently studied in detail at the University of Glasgow. MMP-1, -2 and -9 are overexpressed in sarcoid fibroblasts and decreased expression of viral genes by E2 siRNA treatment effectively reduced MMP expression, demonstrating the link between viral infection and MMP expression [37] . In particular, MMP-1 over-expression was shown to be driven by E6 and E7 through the activator protein-1 (AP-1) transcription factor [38] , and by E5 through an indirect mechanism. However, only E5 and E6 were found to confer invasiveness and enhanced proliferation to equine fibroblasts in vitro, while E7 was associated with anchorage-independent growth [39] . E5 and E6 induce the overexpression of p38 mitogenactivated protein kinase (MAPK), which in turn leads to phosphorylation of an AP-1 component (Fra-1), triggering MMP-1 expression. Both increased proliferation and invasiveness were shown to be mediated by MAPK [40] . The MAPK-AP-1-MMP-1 signalling cascade was thus shown to be involved in the invasiveness of equine sarcoid fibroblasts.
BPV-mediated immune evasion
Evading the host's innate and adaptive immune responses is essential for maintaining viral infection. BPV E5 helps to block the interactions between infected cells and their surrounding environment, especially by irreversibly down- Fig. 3 Interaction between BPV-4 and some bracken toxins in upper digestive carcinogenesis. BPV-4 infects normal epithelial cells (grey), initiating exophytic proliferations (papillomas, in blue), which show virion production (red) and E7 oncoprotein expression (yellow). In a second phase, quercetin (1) is proposed to up-regulate E7 expression, while ptaquiloside (2) blocks natural killer (NK) cell function, reducing immunosurveillance, and contributes to genomic instability, promoting carcinogenesis and leading to oro-oesophageal carcinomas (violet) regulating major histocompatibility complex class I (MHC I) expression. This is achieved in a variety of ways, including the disruption of protein assemblage and traffic at the Golgi apparatus, thus preventing MHC I from being displayed on the cell surface [21] . Impaired protein oligomerization in the Golgi apparatus was also the mechanism proposed to explain connexin 43 down-regulation and the loss of intercellular gap junctions in bovine bladder carcinomas (Fig. 2) [41] . This loss of gap junctions is likely to contribute to making infected cells refractory to inhibitory signals from neighbouring cells.
BPV-1 was also the first papillomavirus found to downregulate the expression of Toll-like receptor 4 (TLR4) through its oncoproteins E2 and E7, using transfected equine fibroblasts cultures in vitro [42] . TLRs are involved in triggering the innate immune response, and accordingly, TLR4 down-regulation is expected to contribute to immune evasion and viral persistence.
Recent findings show how ptaquiloside, the main bracken carcinogen, helps to inhibit the innate immune response. Ptaquiloside has been shown to enhance the expression of metallothienin-1 and -2 in natural killer (NK) cells, resulting in lower intracellular zinc concentrations and in NK function down-regulation [43, 44] (Fig. 3) . One of the functions of NK cells is to destroy virus-infected cells and certain tumour cells. In the context of papillomavirus infection, this immunosuppressive effect is likely to promote viral persistence and tumour development. The same group demonstrated that NK cell function can be restored upon selenium administration [45] . These findings highlight the importance of environmental immunosuppressants, such as bracken, in the pathogenesis of papillomavirus-induced tumours.
BPV persistence, latency and transmission
The E2 protein associates with the host's chromatin and with the viral genome during mitosis, allowing maintenance of the virus in dividing cells. The actual mechanisms through which the E2 protein tethers papillomaviral episomes to host chromosomes are the subject of intense debate [46] . Using synchronised live cells, Feeney et al. [47] have shown that the DNA helicase ChlR1 is required for the association of BPV-1 E2 with chromosomes. In their recent paper, the authors proposed that ChlR1 is required for loading E2-associated viral genomes onto chromosomes during the S phase, but not for their retention during mitosis.
The transcriptional regulator functions of E2 proteins have also been studied using BPV. A recent study describes the different regulator activities of the full-length E2 protein (E2-TA) and of its two truncated isoforms, E2-TR and E8E2 [48] , both of which have been described as transcriptional repressors. This study showed that, while E8E2 indeed acted as a transcription repressor, E2-TR acted as a transcriptional activator of E2-dependent promoters. However, in contrast to E2-TA, E2-TR activated transcription from a promoter-proximal position and partially inhibited P89, while E8E2 led to complete repression.
Latent BPV-2 infection of peripheral blood lymphocytes, resulting in chromosomal aberrations, has long been known to occur in cattle [49, 50] , However, investigations on viral activity and the expression of viral proteins in peripheral blood mononuclear cells (PBMCs) have only started. Hartl et al. [51] reported that foals challenged intradermally with BPV-1 develop viraemia during the early stages of tumourigenesis. Viral DNA was detected in PMBCs before pseudo-sarcoids become palpable, at day 11-32 post-challenge, and the blood viral load correlates with tumour size. Moreover, E5 mRNA was demonstrated in PMBCs, indicating that viral oncogenes are expressed in these cells. Roperto et al. [52] also reported BPV-2 E5 expression in monocytes, B-lymphocytes, and, especially, CD4
? and CD8 ? T-lymphocytes from cattle with urinary bladder tumours. These two cell populations were the only ones to also show expression of the L1 protein, associated with productive infections, and the authors accordingly concluded that they represent the most important BPV-2 blood reservoir.
In a recent study, viral DNA was also found in the epidermis of horses with inflammatory skin conditions and in the epidermis overlying sarcoids, especially in earlystage, ''occult'', flat lesions [53] . Results of other studies suggest that a transient, productive infection may take place in the overlying epidermis during the early phases of sarcoid development [54, 55] . These important findings raise the possibility of BPV transmission between equids, through direct contact or through fomites.
The presence and replication of BPV-2 in the bovine placenta has also been demonstrated recently [5] . Viral particles were demonstrated by electron microscopy in both endometrial and chorionic epithelial cells. Expression of E2 and E1 was confirmed, together with that of E5, which co-localized with PDGFRb. Although there was already some data to support placental infection by HPV [56, 57] , these important findings confirm that papillomavirus are capable of establishing a productive infection in placental cells in vivo and bring additional support to the hypothesis that children can be infected by HPV in utero.
Prophylactic and therapeutic vaccines
Innovative prophylactic and therapeutic vaccination strategies for equine sarcoids and bovine urinary bladder tumours have recently been advanced, mostly based on the use of virus-like particles (VLPs). In 1996, Kirnbauer et al. [58] first reported in a seminal study that VLPs comprising Bovine papillomavirus pathology 195 the BPV-4 L1 and L2 or only the L1 protein triggered a strong humoural response in calves. This response led to immunity on a subsequent challenge with BPV-4 but did not induce papiloma regression in previously infected animals [52] . Later on, chimeric VLPs comprising BPV-1 L1 and E7 proteins were tested on sarcoid-bearing donkeys [59] and horses [60] for therapeutic purposes. Despite a robust humoural response against L1 [60] and a tendency for tumour regression in some animals, the results were not conclusive. However, very recently, BPV-1 L1 VLPs were tested in a dose-escalation trial for the vaccination of healthy horses and were shown to induce a long-lasting humoural response, which the authors deemed appropriate for protection [8] .
A binary ethylenimine-inactivated and saponized BPV-2 vaccine was also tested against BPV-associated bovine urinary bladder tumours, but no regression was obtained [7] . All these results agree in showing that current BPV vaccination strategies may be more useful for prophylactic rather than therapeutic purposes.
Conclusions
Research on BPV continues to be of use for elucidating the mechanisms underlying virus-induced cell transformation. Indeed, in order to study important topics such as the synergy between papillomavirus and bracken toxins, BPVbased models can hardly be put aside. Research on BPV is also expected to continue providing useful leads and clues concerning the functions of viral proteins, especially E2 and E5. Studies on the mechanisms of viral persistence and transmission through blood lymphocytes and the placenta are of particular interest due to their implications for public health. Important information is also being gained regarding distressing animal pathologies with high economic impact, such as bovine oro-oesophageal and urinary bladder cancer or equine sarcoids. At the same time, the evergrowing number of known BPV types holds the promise of new and unexpected possibilities for studying the molecular biology of papillomavirus.
